Last 12 months
Inside the activity.
0 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2015 Filed Mar 3, 2015 22:21 UTC |
Moriarty Thomas MEVP & General Counsel
|
GrantCommon Stock | 2,257 | $103.87 | $234,434.59 |
DisclosureSEC source: 0001127602-15-009663 · form4.xml · nonDerivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,011.0053 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 22:25 UTC |
GOLD STEPHEN JSVP & CIO
|
GrantStock Unit | 6,991 | $103.87 | $726,155.17 |
DisclosureSEC source: 0001127602-15-009666 · form4.xml · nonDerivative · entry 2 GOLD STEPHEN J · CIK 0001252005 · SVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,991 F2 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 22:25 UTC |
GOLD STEPHEN JSVP & CIO
|
GrantCommon Stock | 1,432 | $103.87 | $148,741.84 |
DisclosureSEC source: 0001127602-15-009666 · form4.xml · nonDerivative · entry 1 GOLD STEPHEN J · CIK 0001252005 · SVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,905.118 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 19, 2015 Filed Feb 20, 2015 21:12 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock | 460 | $102.62 | $47,205.20 |
DisclosureSEC source: 0001127602-15-007390 · form4.xml · nonDerivative · entry 2 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,292.5077 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 18, 2015 Filed Feb 20, 2015 21:12 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock | 339 | $104.10 | $35,289.90 |
DisclosureSEC source: 0001127602-15-007390 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,373.5077 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 07, 2015 Filed Feb 10, 2015 21:18 UTC |
Joyner J. DavidEVP, Sales & Account Services
|
Tax withholdingCommon Stock | 263 | $100.61 | $26,460.43 |
DisclosureSEC source: 0001127602-15-005280 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,092 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 07, 2015 Filed Feb 10, 2015 21:21 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock | 259 | $100.61 | $26,057.99 |
DisclosureSEC source: 0001127602-15-005281 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,687.5077 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| January 21, 2015 Filed Jan 23, 2015 21:40 UTC |
BRACKEN RICHARD MDirector
|
GrantCommon Stock | 703 | $99.50 | $69,948.50 |
DisclosureSEC source: 0001127602-15-002616 · form4.xml · nonDerivative · entry 1 BRACKEN RICHARD M · CIK 0001216830 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 703 F1 · shares: Consists of common stock issued as a pro rata portion of the retainer payable for the Reporting Person's service during the 2014-2015 Board year. Read SEC document |
| January 07, 2015 Filed Jan 8, 2015 21:12 UTC |
Roberts Jonathan CEVP & President, CVS/caremark
|
Exercise / conversionStock Option · Derivative | 86,487 | $0.00 Strike: $41.17 | $0.00 |
DisclosureSEC source: 0001127602-15-001445 · form4.xml · derivative · entry 8 Roberts Jonathan C · CIK 0001410515 · EVP & President, CVS/caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 86,487 shares Expires 2015-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in three annual installments, commencing 4/1/2009. Read SEC document |
| January 07, 2015 Filed Jan 8, 2015 21:12 UTC |
Roberts Jonathan CEVP & President, CVS/caremark
|
SaleCommon Stock | 86,487 | $95.31 | $8,243,075.97 |
DisclosureSEC source: 0001127602-15-001445 · form4.xml · nonDerivative · entry 3 Roberts Jonathan C · CIK 0001410515 · EVP & President, CVS/caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,467.7177 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $94.67 and $95.70 per share. Read SEC document |
| January 07, 2015 Filed Jan 8, 2015 21:12 UTC |
Roberts Jonathan CEVP & President, CVS/caremark
|
Exercise / conversionCommon Stock | 86,487 | $41.17 | $3,560,669.79 |
DisclosureSEC source: 0001127602-15-001445 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · EVP & President, CVS/caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,954.7177 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2015 Filed Jan 6, 2015 22:33 UTC |
MERLO LARRY JDirector · President and CEO
|
Exercise / conversionStock Option · Derivative | 144,144 | $0.00 Strike: $41.17 | $0.00 |
DisclosureSEC source: 0001127602-15-001235 · form4.xml · derivative · entry 9 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 144,144 shares Expires 2015-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2009. Read SEC document |
| January 05, 2015 Filed Jan 6, 2015 22:33 UTC |
MERLO LARRY JDirector · President and CEO
|
SaleCommon Stock | 144,144 | $94.30 | $13,592,779.20 |
DisclosureSEC source: 0001127602-15-001235 · form4.xml · nonDerivative · entry 4 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,129.1029 F2 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F3 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $93.88 and $94.86 per share. Read SEC document |
| January 05, 2015 Filed Jan 6, 2015 22:33 UTC |
MERLO LARRY JDirector · President and CEO
|
Exercise / conversionCommon Stock | 144,144 | $41.17 | $5,934,408.48 |
DisclosureSEC source: 0001127602-15-001235 · form4.xml · nonDerivative · entry 3 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,273.1029 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2015 Filed Jan 5, 2015 21:58 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
Exercise / conversionStock Option · Derivative | 50,240 | $0.00 Strike: $34.96 | $0.00 |
DisclosureSEC source: 0001127602-15-000758 · form4.xml · derivative · entry 4 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,747 Underlying: Common Stock · 50,240 shares Expires 2018-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2012. Read SEC document |
| January 02, 2015 Filed Jan 5, 2015 21:58 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
SaleCommon Stock | 50,240 | $95.71 | $4,808,515.62 |
DisclosureSEC source: 0001127602-15-000758 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,247.059 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $94.40 and $96.85 per share. Read SEC document |
| January 02, 2015 Filed Jan 5, 2015 21:58 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
Exercise / conversionCommon Stock | 50,240 | $34.96 | $1,756,390.40 |
DisclosureSEC source: 0001127602-15-000758 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,487.059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2015 Filed Jan 5, 2015 21:52 UTC | Exercise / conversionStock Option · Derivative | 347,343 | $0.00 Strike: $45.07 | $0.00 |
DisclosureSEC source: 0001127602-15-000743 · form4.xml · derivative · entry 6 Lofberg Per GH · CIK 0001318289 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 347,343 shares Expires 2019-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable on December 31, 2013. Read SEC document |
|
| January 02, 2015 Filed Jan 5, 2015 21:52 UTC | SaleCommon Stock | 347,343 | $95.28 | $33,096,438.82 |
DisclosureSEC source: 0001127602-15-000743 · form4.xml · nonDerivative · entry 2 Lofberg Per GH · CIK 0001318289 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,419 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $94.40 and $96.86 per share. Read SEC document |
|
| January 02, 2015 Filed Jan 5, 2015 21:52 UTC | Exercise / conversionCommon Stock | 347,343 | $45.07 | $15,654,749.01 |
DisclosureSEC source: 0001127602-15-000743 · form4.xml · nonDerivative · entry 1 Lofberg Per GH · CIK 0001318289 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 370,762 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| January 02, 2015 Filed Jan 5, 2015 22:00 UTC |
Sussman AndrewSVP & Pres, CVS/minuteclinic
|
SaleCommon Stock | 4,220 | $95.67 | $403,712.63 |
DisclosureSEC source: 0001127602-15-000767 · form4.xml · nonDerivative · entry 1 Sussman Andrew · CIK 0001515706 · SVP & Pres, CVS/minuteclinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,817.0237 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $94.83 and $96.82 per share. Read SEC document |
| November 28, 2014 Filed Dec 2, 2014 21:15 UTC | GrantStock Option · Derivative | 138,477 | $91.36 Strike: $91.36 | $12,651,258.72 |
DisclosureSEC source: 0001127602-14-033860 · form4.xml · derivative · entry 5 Lofberg Per GH · CIK 0001318289 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,477 Underlying: Common Stock · 138,477 shares Expires 2021-11-28 F1 · derivative.exercise_date: Option becomes exercisable on December 31, 2015. Read SEC document |
|
| November 07, 2014 Filed Nov 10, 2014 22:11 UTC |
Foulkes HelenaEVP, President-CVS/pharmacy
|
Exercise / conversionStock Option · Derivative | 12,058 | $0.00 Strike: $34.96 | $0.00 |
DisclosureSEC source: 0001127602-14-031766 · form4.xml · derivative · entry 13 Foulkes Helena · CIK 0001429996 · EVP, President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,058 Underlying: Common Stock · 12,058 shares Expires 2018-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2012. Read SEC document |
| November 07, 2014 Filed Nov 10, 2014 22:11 UTC |
Foulkes HelenaEVP, President-CVS/pharmacy
|
Exercise / conversionStock Option · Derivative | 14,303 | $0.00 Strike: $34.96 | $0.00 |
DisclosureSEC source: 0001127602-14-031766 · form4.xml · derivative · entry 12 Foulkes Helena · CIK 0001429996 · EVP, President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,607 Underlying: Common Stock · 14,303 shares Expires 2021-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2014. Read SEC document |
| November 07, 2014 Filed Nov 10, 2014 22:11 UTC |
Foulkes HelenaEVP, President-CVS/pharmacy
|
Exercise / conversionStock Option · Derivative | 19,964 | $0.00 Strike: $45.07 | $0.00 |
DisclosureSEC source: 0001127602-14-031766 · form4.xml · derivative · entry 11 Foulkes Helena · CIK 0001429996 · EVP, President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,965 Underlying: Common Stock · 19,964 shares Expires 2019-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| November 07, 2014 Filed Nov 10, 2014 22:11 UTC |
Foulkes HelenaEVP, President-CVS/pharmacy
|
SaleCommon Stock | 12,058 | $88.07 | $1,061,920.33 |
DisclosureSEC source: 0001127602-14-031766 · form4.xml · nonDerivative · entry 6 Foulkes Helena · CIK 0001429996 · EVP, President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,075.9739 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F4 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $87.75 and $88.38 per share. Read SEC document |
| November 07, 2014 Filed Nov 10, 2014 22:11 UTC |
Foulkes HelenaEVP, President-CVS/pharmacy
|
Exercise / conversionCommon Stock | 12,058 | $34.96 | $421,547.68 |
DisclosureSEC source: 0001127602-14-031766 · form4.xml · nonDerivative · entry 5 Foulkes Helena · CIK 0001429996 · EVP, President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,133.9739 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2014 Filed Nov 10, 2014 22:11 UTC |
Foulkes HelenaEVP, President-CVS/pharmacy
|
SaleCommon Stock | 14,303 | $88.07 | $1,259,632.31 |
DisclosureSEC source: 0001127602-14-031766 · form4.xml · nonDerivative · entry 4 Foulkes Helena · CIK 0001429996 · EVP, President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,075.9739 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F3 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $87.75 and $88.38 per share. Read SEC document |
| November 07, 2014 Filed Nov 10, 2014 22:11 UTC |
Foulkes HelenaEVP, President-CVS/pharmacy
|
Exercise / conversionCommon Stock | 14,303 | $34.96 | $500,032.88 |
DisclosureSEC source: 0001127602-14-031766 · form4.xml · nonDerivative · entry 3 Foulkes Helena · CIK 0001429996 · EVP, President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,378.9739 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2014 Filed Nov 10, 2014 22:11 UTC |
Foulkes HelenaEVP, President-CVS/pharmacy
|
SaleCommon Stock | 19,964 | $88.06 | $1,758,031.84 |
DisclosureSEC source: 0001127602-14-031766 · form4.xml · nonDerivative · entry 2 Foulkes Helena · CIK 0001429996 · EVP, President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,075.9739 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $87.80 and $88.38 per share. Read SEC document |
| November 07, 2014 Filed Nov 10, 2014 22:11 UTC |
Foulkes HelenaEVP, President-CVS/pharmacy
|
Exercise / conversionCommon Stock | 19,964 | $45.07 | $899,777.48 |
DisclosureSEC source: 0001127602-14-031766 · form4.xml · nonDerivative · entry 1 Foulkes Helena · CIK 0001429996 · EVP, President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,039.9739 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2014 Filed Dec 2, 2014 21:15 UTC | GiftCommon Stock | 22,981 | $88.43 | $2,032,209.83 |
DisclosureSEC source: 0001127602-14-033860 · form4.xml · nonDerivative · entry 1 Lofberg Per GH · CIK 0001318289 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,419 Read SEC document |
|
| November 05, 2014 Filed Nov 6, 2014 22:00 UTC |
BROWN C DAVID IIDirector
|
GrantShare Credits · Derivative | 1,714.2857 | $87.50 Strike: $0.00 | $150,000.00 |
DisclosureSEC source: 0001127602-14-031473 · form4.xml · derivative · entry 2 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,255.6596 Underlying: Common Stock · 1,714.2857 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 05, 2014 Filed Nov 6, 2014 22:01 UTC |
DEPARLE NANCY ANNDirector
|
GrantShare Credits · Derivative | 800 | $87.50 Strike: $0.00 | $70,000.00 |
DisclosureSEC source: 0001127602-14-031475 · form4.xml · derivative · entry 2 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,761.7535 Underlying: Common Stock · 800 shares Expires not disclosed F2 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F3 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F3 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 05, 2014 Filed Nov 6, 2014 22:01 UTC |
DEPARLE NANCY ANNDirector
|
GrantCommon Stock | 600 | $87.50 | $52,500.00 |
DisclosureSEC source: 0001127602-14-031475 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,617 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| November 05, 2014 Filed Nov 6, 2014 22:02 UTC |
Finucane Anne A.Director
|
GrantShare Credits · Derivative | 1,200 | $87.50 Strike: $0.00 | $105,000.00 |
DisclosureSEC source: 0001127602-14-031477 · form4.xml · derivative · entry 3 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,593.5407 Underlying: Common Stock · 1,200 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election Read SEC document |
| November 05, 2014 Filed Nov 6, 2014 22:03 UTC |
SWIFT RICHARD JDirector
|
GrantShare Credits · Derivative | 1,307.1429 | $87.50 Strike: $0.00 | $114,375.00 |
DisclosureSEC source: 0001127602-14-031478 · form4.xml · derivative · entry 2 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,864.9766 Underlying: Common Stock · 1,307.1429 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 05, 2014 Filed Nov 6, 2014 22:04 UTC |
WELDON WILLIAM CDirector
|
GrantShare Credits · Derivative | 1,600 | $87.50 Strike: $0.00 | $140,000.00 |
DisclosureSEC source: 0001127602-14-031479 · form4.xml · derivative · entry 2 WELDON WILLIAM C · CIK 0001189019 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,740.6151 Underlying: Common Stock · 1,600 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 05, 2014 Filed Nov 6, 2014 22:06 UTC |
MILLON JEAN PIERREDirector
|
GrantCommon Stock | 1,200 | $87.50 | $105,000.00 |
DisclosureSEC source: 0001127602-14-031480 · form4.xml · nonDerivative · entry 1 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,200 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| November 05, 2014 Filed Nov 6, 2014 22:07 UTC |
DORMAN DAVID WDirector
|
GrantCommon Stock | 3,257 | $87.50 | $284,987.50 |
DisclosureSEC source: 0001127602-14-031481 · form4.xml · nonDerivative · entry 1 DORMAN DAVID W · CIK 0001082870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,739 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| November 05, 2014 Filed Nov 6, 2014 22:08 UTC |
WHITE TONY LDirector
|
GrantCommon Stock | 1,200 | $87.50 | $105,000.00 |
DisclosureSEC source: 0001127602-14-031482 · form4.xml · nonDerivative · entry 1 WHITE TONY L · CIK 0001171315 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,302 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| October 27, 2014 Filed Oct 28, 2014 20:07 UTC |
Bisaccia LisaSVP, Chief HR Officer
|
Exercise / conversionStock Option · Derivative | 12,058 | $0.00 Strike: $34.96 | $0.00 |
DisclosureSEC source: 0001127602-14-030378 · form4.xml · derivative · entry 10 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,058 Underlying: Common Stock · 12,058 shares Expires 2018-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2012. Read SEC document |
| October 27, 2014 Filed Oct 28, 2014 20:07 UTC |
Bisaccia LisaSVP, Chief HR Officer
|
Exercise / conversionStock Option · Derivative | 15,528 | $0.00 Strike: $45.07 | $0.00 |
DisclosureSEC source: 0001127602-14-030378 · form4.xml · derivative · entry 9 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,528 Underlying: Common Stock · 15,528 shares Expires 2019-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| October 27, 2014 Filed Oct 28, 2014 20:07 UTC |
Bisaccia LisaSVP, Chief HR Officer
|
SaleCommon Stock | 5,921 | $85.00 | $503,285.00 |
DisclosureSEC source: 0001127602-14-030378 · form4.xml · nonDerivative · entry 5 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,281 F1 · kind: All transactions were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| October 27, 2014 Filed Oct 28, 2014 20:07 UTC |
Bisaccia LisaSVP, Chief HR Officer
|
SaleCommon Stock | 12,058 | $85.00 | $1,024,930.00 |
DisclosureSEC source: 0001127602-14-030378 · form4.xml · nonDerivative · entry 4 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,202 F1 · kind: All transactions were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| October 27, 2014 Filed Oct 28, 2014 20:07 UTC |
Bisaccia LisaSVP, Chief HR Officer
|
Exercise / conversionCommon Stock | 12,058 | $34.96 | $421,547.68 |
DisclosureSEC source: 0001127602-14-030378 · form4.xml · nonDerivative · entry 3 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,260 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 27, 2014 Filed Oct 28, 2014 20:07 UTC |
Bisaccia LisaSVP, Chief HR Officer
|
SaleCommon Stock | 15,528 | $85.00 | $1,319,880.00 |
DisclosureSEC source: 0001127602-14-030378 · form4.xml · nonDerivative · entry 2 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,202 F1 · kind: All transactions were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| October 27, 2014 Filed Oct 28, 2014 20:07 UTC |
Bisaccia LisaSVP, Chief HR Officer
|
Exercise / conversionCommon Stock | 15,528 | $45.07 | $699,846.96 |
DisclosureSEC source: 0001127602-14-030378 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,730 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2014 Filed Sep 3, 2014 20:43 UTC |
Sussman AndrewSVP & President, MinuteClinic
|
Exercise / conversionStock Option · Derivative | 9,020 | $0.00 Strike: $36.96 | $0.00 |
DisclosureSEC source: 0001127602-14-027093 · form4.xml · derivative · entry 6 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,020 shares Expires 2019-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 9/1/2012. Read SEC document |
| September 02, 2014 Filed Sep 3, 2014 20:43 UTC |
Sussman AndrewSVP & President, MinuteClinic
|
SaleCommon Stock | 9,020 | $79.45 | $716,639.00 |
DisclosureSEC source: 0001127602-14-027093 · form4.xml · nonDerivative · entry 3 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,037.0237 F2 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.